256 related articles for article (PubMed ID: 30919333)
1. Targeting Mitochondrial Defects to Increase Longevity in Animal Models of Neurodegenerative Diseases.
Casajus Pelegay E; Puzzo F; Yilmazer A; Cagin U
Adv Exp Med Biol; 2019; 1134():89-110. PubMed ID: 30919333
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease.
Hroudová J; Singh N; Fišar Z
Biomed Res Int; 2014; 2014():175062. PubMed ID: 24900954
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases.
Correia SC; Santos RX; Perry G; Zhu X; Moreira PI; Smith MA
Adv Exp Med Biol; 2012; 724():205-21. PubMed ID: 22411245
[TBL] [Abstract][Full Text] [Related]
5. Neurodegeneration as a consequence of failed mitochondrial maintenance.
Karbowski M; Neutzner A
Acta Neuropathol; 2012 Feb; 123(2):157-71. PubMed ID: 22143516
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial homeostatic disruptions are sensitive indicators of stress in neurons with defective mitochondrial DNA transactions.
Hung KM; Calkins MJ
Mitochondrion; 2016 Nov; 31():9-19. PubMed ID: 27581214
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dynamics, a key executioner in neurodegenerative diseases.
Panchal K; Tiwari AK
Mitochondrion; 2019 Jul; 47():151-173. PubMed ID: 30408594
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria, lysosomes, and dysfunction: their meaning in neurodegeneration.
Audano M; Schneider A; Mitro N
J Neurochem; 2018 Nov; 147(3):291-309. PubMed ID: 29804302
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species: stuck in the middle of neurodegeneration.
Patten DA; Germain M; Kelly MA; Slack RS
J Alzheimers Dis; 2010; 20 Suppl 2():S357-67. PubMed ID: 20421690
[TBL] [Abstract][Full Text] [Related]
10. Autophagy and Mitochondria: Targets in Neurodegenerative Disorders.
Kumar A; Dhawan A; Kadam A; Shinde A
CNS Neurol Disord Drug Targets; 2018; 17(9):696-705. PubMed ID: 30113005
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
12. Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders.
Mattson MP; Liu D
Neuromolecular Med; 2002; 2(2):215-31. PubMed ID: 12428812
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant modulation in restoring mitochondrial function in neurodegeneration.
Pahrudin Arrozi A; Wan Ngah WZ; Mohd Yusof YA; Ahmad Damanhuri MH; Makpol S
Int J Neurosci; 2017 Mar; 127(3):218-235. PubMed ID: 27074540
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria, oxidative stress and neurodegeneration.
Federico A; Cardaioli E; Da Pozzo P; Formichi P; Gallus GN; Radi E
J Neurol Sci; 2012 Nov; 322(1-2):254-62. PubMed ID: 22669122
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria and neurodegenerative diseases: Special issue of BMB Reports in 2020.
Chung KC
BMB Rep; 2020 Jan; 53(1):1-2. PubMed ID: 31865963
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria as a therapeutic target for aging and neurodegenerative diseases.
Reddy PH; Reddy TP
Curr Alzheimer Res; 2011 Jun; 8(4):393-409. PubMed ID: 21470101
[TBL] [Abstract][Full Text] [Related]
17. Perspectives of drug-based neuroprotection targeting mitochondria.
Procaccio V; Bris C; Chao de la Barca JM; Oca F; Chevrollier A; Amati-Bonneau P; Bonneau D; Reynier P
Rev Neurol (Paris); 2014 May; 170(5):390-400. PubMed ID: 24792485
[TBL] [Abstract][Full Text] [Related]
18. Role of mitochondrial ROS in the brain: from physiology to neurodegeneration.
Angelova PR; Abramov AY
FEBS Lett; 2018 Mar; 592(5):692-702. PubMed ID: 29292494
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease.
Nissanka N; Moraes CT
FEBS Lett; 2018 Mar; 592(5):728-742. PubMed ID: 29281123
[TBL] [Abstract][Full Text] [Related]
20. Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration.
Jha SK; Jha NK; Kumar D; Ambasta RK; Kumar P
Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1132-1146. PubMed ID: 27345267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
